{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:53:58Z","timestamp":1787615638917,"version":"build-2736575974"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":551,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019341","name":"Medtronic Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011953","name":"Abbott Medical Optics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019341","name":"Medtronic Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011953","name":"Abbott Medical Optics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>A considerable proportion of candidates for transcatheter aortic valve implantation (TAVI) have underlying heart failure (HF) with preserved ejection fraction (HFpEF), which can be challenging for diagnosis because significant valvular heart disease should be excluded before diagnosing HFpEF. This study investigated the long-term prognostic value of the pre-procedural H2FPEF score in patients with preserved ejection fraction (EF) undergoing TAVI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Patients who underwent TAVI between October 2013 and May 2017 were enrolled from the Optimized CathEter vAlvular iNtervention\u2013Transcatheter Aortic Valve Implantation Japanese multicentre registry. After excluding 914 patients, 1674 patients with preserved EF \u2265 50% (median age: 85 years, 72% female) were selected for calculation of the H2FPEF score and were dichotomized into two groups: the low H2FPEF score [0\u20135 points; n = 1399 (83.6%)] group and the high H2FPEF score [6\u20139 points; n = 275 (16.4%)] group. Patients with high H2FPEF scores were associated with a higher prevalence of New York Heart Association Functional Class III\/IV (59.3% vs. 43.7%, P &amp;lt; 0.001), diabetes (24.4% vs. 18.5%, P = 0.03), and paradoxical low-flow, low-gradient aortic stenosis (15.9% vs. 6.2%, P &amp;lt; 0.001). These patients showed worse prognoses than those with low H2FPEF scores regarding the cumulative 2 year all-cause mortality (26.3% vs. 15.5%, log-rank P &amp;lt; 0.001), cardiovascular mortality (10.5% vs. 5.4%, log-rank P &amp;lt; 0.001), HF hospitalization (16.2% vs. 6.7%, log-rank P &amp;lt; 0.001), and the composite endpoint of cardiovascular mortality and HF hospitalization (23.8% vs. 10.8%, log-rank P &amp;lt; 0.001). After adjustment for several confounders, the high H2FPEF scores were independently associated with increased risk for all-cause mortality [adjusted hazard ratio (HR), 1.48; 95% confidence interval (CI), 1.09\u20132.00; P = 0.011] and for the composite endpoint of cardiovascular mortality and HF hospitalization (adjusted HR, 1.95; 95% CI, 1.38\u20132.74; P &amp;lt; 0.001). Subgroup analysis confirmed the excess risk of high H2FPEF scores relative to low H2FPEF scores for the composite endpoint of cardiovascular mortality and HF hospitalization increased with a lower Society of Thoracic Surgeons (STS) score (STS score &amp;lt;8%: adjusted HR, 2.40; 95% CI, 1.50\u20133.85; P &amp;lt; 0.001; STS score \u22658%: adjusted HR, 1.34; 95% CI, 0.79\u20132.28; P = 0.28; Pinteraction = 0.030).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The H2FPEF score is useful for predicting long-term adverse outcomes after TAVI, including all-cause mortality, cardiovascular mortality, and HF hospitalization for patients with preserved EF. More aggressive interventions targeting HFpEF in addition to the TAVI procedure might be relevant in patients with high H2FPEF scores, particularly in those with a lower surgical risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14773","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T10:18:59Z","timestamp":1712917139000},"page":"2159-2171","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-Term Prognostic Value of the H2FPEF Score in Patients Undergoing Transcatheter Aortic Valve Implantation"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3551-5525","authenticated-orcid":false,"given":"Kenichi","family":"Ishizu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Shirai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Isotani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kakumoto","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Yashima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Utsunomiya Hospital , Utsunomiya ,","place":["Japan"]},{"name":"Department of Cardiology, Keio University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sendai Kosei Hospital , Sendai ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamawaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Yokohama City Eastern Hospital , Yokohama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Naganuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, New Tokyo Hospital , Matsudo ,","place":["Japan"]},{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University , Kumamoto ,","place":["Japan"]},{"name":"Department of Cardiology, Shonan Kamakura General Hospital , Kamakura ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toyama University Hospital , Toyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Tokyo Bay Urayasu Ichikawa Medical Center , Urayasu ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Faculty of Medicine, Kindai University , Osakasayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center , Suita ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Toyohashi Heart Center , Toyohashi ,","place":["Japan"]},{"name":"Department of Cardiology, Nagoya Heart Center , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hayashida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"OCEAN-TAVI Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"2026012113134872900_ehf214773-bib-0001","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/CIRCULATIONAHA.118.039136","article-title":"Differential clinical profiles, exercise responses, and outcomes associated with existing HFpEF definitions","volume":"140","author":"Ho","year":"2019","journal-title":"Circulation"},{"key":"2026012113134872900_ehf214773-bib-0002","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012113134872900_ehf214773-bib-0003","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"2026012113134872900_ehf214773-bib-0004","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ehf2.12570","article-title":"H2FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors","volume":"7","author":"Suzuki","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012113134872900_ehf214773-bib-0005","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/ehf2.13187","article-title":"Predictive value of H2FPEF score in patients with heart failure with preserved ejection fraction","volume":"8","author":"Sun","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012113134872900_ehf214773-bib-0006","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/eurheartj\/ehx381","article-title":"Staging classification of aortic stenosis based on the extent of cardiac damage","volume":"38","author":"G\u00e9n\u00e9reux","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012113134872900_ehf214773-bib-0007","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jcin.2017.09.010","article-title":"Incidence, prognostic impact, and predictive factors of readmission for heart failure after transcatheter aortic valve replacement","volume":"10","author":"Durand","year":"2017","journal-title":"J Am Coll Cardiol Intv"},{"key":"2026012113134872900_ehf214773-bib-0008","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jcin.2015.07.022","article-title":"Incidence, causes, and predictors of early (\u226430 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement","volume":"8","author":"Nombela-Franco","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"2026012113134872900_ehf214773-bib-0009","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ehf2.13096","article-title":"Prognostic value of the H2FPEF score in patients undergoing transcatheter aortic valve implantation","volume":"8","author":"Ludwig","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012113134872900_ehf214773-bib-0010","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"Can Med Assoc J"},{"key":"2026012113134872900_ehf214773-bib-0011","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.amjcard.2016.05.052","article-title":"Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer","volume":"118","author":"Watanabe","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026012113134872900_ehf214773-bib-0012","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.010097","article-title":"Aspirin versus clopidogrel as single antithrombotic therapy after transcatheter aortic valve replacement: Insight from the OCEAN-TAVI registry","volume":"14","author":"Kobari","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2026012113134872900_ehf214773-bib-0013","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jtcvs.2012.09.002","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document","volume":"145","author":"Kappetein","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012113134872900_ehf214773-bib-0014","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012113134872900_ehf214773-bib-0015","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.amjcard.2021.03.027","article-title":"Long-term prognostic value of the Society of Thoracic Surgery risk score in patients undergoing transcatheter aortic valve implantation (from the OCEAN-TAVI registry)","volume":"149","author":"Ishizu","year":"2021","journal-title":"Am J Cardiol"},{"key":"2026012113134872900_ehf214773-bib-0016","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.114.013947","article-title":"Transcatheter aortic valve implantation in the United Kingdom: Temporal trends, predictors of outcome, and 6-year follow-up: A report from the UK Transcatheter Aortic Valve Implantation (TAVI) registry, 2007 to 2012","volume":"131","author":"Ludman","year":"2015","journal-title":"Circulation"},{"key":"2026012113134872900_ehf214773-bib-0017","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.amjcard.2019.10.014","article-title":"Predictors of in-hospital mortality after transcatheter aortic valve implantation","volume":"125","author":"Krittanawong","year":"2020","journal-title":"Am J Cardiol"},{"key":"2026012113134872900_ehf214773-bib-0018","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: The HFA-PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012113134872900_ehf214773-bib-0019","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012113134872900_ehf214773-bib-0020","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jchf.2018.03.003","article-title":"Hemodynamic correlates and diagnostic role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction","volume":"6","author":"Reddy","year":"2018","journal-title":"JACC: Heart Fail"},{"key":"2026012113134872900_ehf214773-bib-0021","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"2026012113134872900_ehf214773-bib-0022","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/ehf2.13885","article-title":"Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction","volume":"9","author":"Hamada","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012113134872900_ehf214773-bib-0023","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/ehf2.13254","article-title":"The impact of frailty according to Clinical Frailty Scale on clinical outcome in patients with heart failure","volume":"8","author":"Kanenawa","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012113134872900_ehf214773-bib-0024","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1161\/CIRCULATIONAHA.116.025630","article-title":"Impact of the Clinical Frailty Scale on outcomes after transcatheter aortic valve replacement","volume":"135","author":"Shimura","year":"2017","journal-title":"Circulation"},{"key":"2026012113134872900_ehf214773-bib-0025","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012113134872900_ehf214773-bib-0026","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012113134872900_ehf214773-bib-0027","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1016\/j.jacc.2015.09.076","article-title":"Outcome and impact of aortic valve replacement in patients with preserved LVEF and low-gradient aortic stenosis","volume":"66","author":"Dayan","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012113134872900_ehf214773-bib-0028","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4244\/EIJ-D-19-00399","article-title":"Early haemodynamic changes and long-term outcome of patients with severe low-gradient aortic stenosis after transcatheter aortic valve replacement","volume":"15","author":"Schewel","year":"2020","journal-title":"EuroIntervention"},{"key":"2026012113134872900_ehf214773-bib-0029","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2016.12.028","article-title":"Prognostic impact of low-flow severe aortic stenosis in small-body patients undergoing TAVR: The OCEAN-TAVI registry","volume":"11","author":"Kataoka","year":"2018","journal-title":"J Am Coll Cardiol Img"},{"key":"2026012113134872900_ehf214773-bib-0030","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ehf2.13774","article-title":"HFA-PEFF score: Prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation","volume":"9","author":"Seoudy","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012113134872900_ehf214773-bib-0031","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1136\/heartjnl-2017-311506","article-title":"The role and clinical implications of diastolic dysfunction in aortic stenosis","volume":"103","author":"Kampaktsis","year":"2017","journal-title":"Heart"},{"key":"2026012113134872900_ehf214773-bib-0032","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005798","article-title":"Reversibility of cardiac function predicts outcome after transcatheter aortic valve replacement in patients with severe aortic stenosis","volume":"6","author":"Sato","year":"2017","journal-title":"J Am Heart Assoc"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/4\/2159\/64526807\/eschf_11_4_2159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/4\/2159\/64526807\/eschf_11_4_2159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:15:35Z","timestamp":1769019335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/4\/2159\/8271173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,12]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14773","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"2022-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}